Skip to main content
Nanomedicine-1920
Article

Assessing nanomedicine delivery across the blood-brain barrier using pre-clinical in vivo imaging

We recently spoke to researchers based at the Centre for Advanced Imaging at the University of Queensland in Australia who have been utilizing various pre-clinical in vivo imaging techniques to explore the uptake of custom-designed nanomedicines at different stages of brain cancer.

In this article, Professor Kris Thurecht, Dr. Zachary H. Houston, and Dr. Nick Fletcher discuss the rationale behind their approach and the personalized therapeutic potential of this methodology for patients with brain tumors in the future.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Assessing nanomedicine delivery across the blood-brain barrier using pre-clinical in vivo imaging

Download Article